The provided texts explore the influence of Big Pharma on American healthcare policy and the resulting high drug prices, particularly focusing on insulin costs. One source features a discussion about the connection between pharmaceutical industry funding, FDA policies, and the SNAP program's contribution to poor health outcomes through the purchase of processed foods. Another source details how the Trump administration's actions, including staffing choices and policy decisions, benefitted the pharmaceutical industry at the expense of consumers. A final source from the Center for American Progress examines the substantial profits of pharmaceutical companies, highlighting government subsidies and manipulative pricing strategies that harm patients and exacerbate health inequalities.